35 research outputs found

    IGF-1 does not moderate the time-dependent transcriptional patterns of key homeostatic genes induced by sustained compression of bovine cartilage

    Get PDF
    Objective To determine changes in chondrocyte transcription of a range of anabolic, catabolic and signaling genes following simultaneous treatment of cartilage with Insulin-like growth factor-1 (IGF-1) and ramp-and-hold mechanical compression, and compare with effects on biosynthesis. Methods Explant disks of bovine calf cartilage were slowly compressed (unconfined) over 3-min to their 1 mm cut-thickness (0%-compression) or to 50%-compression with or without 300 ng/ml IGF-1. Expression of 24 genes involved in cartilage homeostasis was measured using qPCR at 2, 8, 24, 32, 48 h after compression ±IGF-1. Clustering analysis was used to identify groups of co-expressed genes to further elucidate mechanistic pathways. Results IGF-1 alone stimulated gene expression of aggrecan and collagen II, but simultaneous 24h compression suppressed this effect. Compression alone up-regulated expression of matrix metalloproteinase (MMP)-3, MMP-13, a disintegrin and metalloproteinase with thrombospondin motif (ADAMTS)-5 and transforming growth factor (TGF)-β, an effect not reversed by simultaneous IGF-1 treatment. Temporal changes in expression following IGF-1 treatment were generally slower than that following compression. Clustering analysis revealed five distinct groups within which the pairings, tissue inhibitor of metalloproteinase (TIMP)-3 and ADAMTS-5, MMP-1 and IGF-2, and IGF-1 and Collagen II, were all robustly co-expressed, suggesting inherent regulation and feedback in chondrocyte gene expression. While aggrecan synthesis was transcriptionally regulated by IGF-1, inhibition of aggrecan synthesis by sustained compression appeared post-transcriptionally regulated. Conclusion Sustained compression markedly altered the effects of IGF-1 on expression of genes involved in cartilage homeostasis, while IGF-1 was largely unable to moderate the transcriptional effects of compression alone. The demonstrated co-expressed gene pairings suggest a balance of anabolic and catabolic activity following simultaneous mechanical and growth factor stimuli.National Institutes of Health (U.S.) (grant R01-AR33236)National Institutes of Health (U.S.) (grant R01-HG003352)National Institutes of Health (U.S.) (grant P42-ES04699)National Institutes of Health (U.S.) (grant T32-EB006348

    A Measurement of the Product Branching Ratio f(b->Lambda_b).BR(Lambda_b->Lambda X) in Z0 Decays

    Get PDF
    The product branching ratio, f(b->Lambda_b).BR(Lambda_b->Lambda X), where Lambda_b denotes any weakly-decaying b-baryon, has been measured using the OPAL detector at LEP. Lambda_b are selected by the presence of energetic Lambda particles in bottom events tagged by the presence of displaced secondary vertices. A fit to the momenta of the Lambda particles separates signal from B meson and fragmentation backgrounds. The measured product branching ratio is f(b->Lambda_b).BR(Lambda_b->Lambda X) = (2.67+-0.38(stat)+0.67-0.60(sys))% Combined with a previous OPAL measurement, one obtains f(b->Lambda_b).BR(Lambda_b->Lambda X) = (3.50+-0.32(stat)+-0.35(sys))%.Comment: 16 pages, LaTeX, 3 eps figs included, submitted to the European Physical Journal

    Experimental progress in positronium laser physics

    Get PDF

    Virulence Factors IN Fungi OF Systemic Mycoses

    Full text link

    Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    Get PDF
    Background: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings: Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79). Interpretation: In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

    Genotypic variability in subarctic Atlantic planktic foraminifera

    No full text
    Specimens of the planktic foraminiferal morphospecies, Globigerina bulloides, Turborotalita quinqueloba, Neogloboquadrina pachyderma (dextral) and Globigerinita uvula, were collected along a subarctic Atlantic transect. Partial sequences of the small subunit (SSU) ribosomal (r) RNA gene were obtained and a distance-based foraminiferal phylogeny constructed. The low latitude morphospecies, Globigerina falconensis, was included to improve within cluster resolution. G. bulloides, G. falconensis and T. quinqueloba cluster together as a distinct group within the molecular phylogeny. The diversification of these three morphospecies from their common ancestor is clearly later than the main planktic spinose radiation, consistent with current interpretations of the fossil record. G. bulloides and G. falconensis are highly divergent from one another, supporting palaeontological and biological evidence that they are separate species. N. pachyderma (dextral) clusters with Neogloboquadrina dutertrei within the benthic and non-spinose planktic region of the tree. G. uvula also clusters within the benthic and non-spinose planktic region of the tree, adjacent to Globigerinita glutinata, a member of the same genus, though resolution is too low to provide evidence of a sister-taxon relationship. The Globigerina bulloides and Turborotalita quinqueloba morphospecies comprise a complex of distinct SSU rDNA genetic types. These fall into two groups, representing high and low latitude genotypes. Along the subarctic transect, G. bulloides and T. quinqueloba were each represented by two distinct genotypes. Neogloboquadrina pachyderma (dextral) and Globigerinita uvula were each represented by a single genotype. Genotypes of a morphospecies exhibit distinctive and different distribution patterns. In the case of Globigerina bulloides, the genotype distribution is suggestive of differing adaptation. However, the Turborotalita quinqueloba genotype distribution was complicated by their co-existence in the same water column throughout the eastern sector. Further investigation will be required to determine whether they occupy a different niche within the water column. Although only T. quinqueloba Type IIa was found in the western region, sampling density was low and inconclusive. The Neogloboquadrina pachyderma (dextral) genotype was found across the entire transect. Further investigation of genotype distribution and genotype/habitat relationships could provide new high-resolution proxies for past oceanographic/climate reconstructions. © 2001 Elsevier Science B.V. All rights reserved
    corecore